MD
MD.US Pediatrix Medical Group, Inc.
- Market cap
- USD 2.45B
- P/E
- 17.1x
- P/B
- 2.88x
- ROE
- 18.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is MD.US undervalued?
Graham numberMD.US trades 47.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pediatrix Medical Group, Inc. fundamental analysis
No fundamental analysis for Pediatrix Medical Group, Inc. yet.
Pediatrix Medical Group, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to…
Full company profilePediatrix Medical Group, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pediatrix Medical Group, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.18B | 3.46B | 3.65B | 1.78B | 1.73B | 1.91B | 1.97B | 1.99B | 2.01B | 1.91B | 1.95B |
| Gross Profit | 1.03B | 1.00B | 990M | 503M | 449M | 513M | 467M | 422M | 454M | 472M | 514M |
| Operating Income | 572M | 480M | 446M | 172M | 98.1M | 203M | 173M | 7.32M | -68.7M | 231M | 225M |
| EBITDA | 661M | 588M | 468M | 204M | 146M | 236M | 157M | 29.9M | -28.4M | 274M | 253M |
| Net Income | 325M | 320M | 269M | -1.50B | -796M | 131M | 66.3M | -60.4M | -99.1M | 165M | 155M |
| EPS | 3.47 | 3.42 | 2.93 | -18 | -9.31 | 1.52 | 0.79 | -0.73 | -1.19 | 1.94 | 1.95 |
| Balance Sheet | |||||||||||
| Total Assets | 5.34B | 5.87B | 5.93B | 4.15B | 3.35B | 2.72B | 2.35B | 2.22B | 2.15B | 2.25B | 2.14B |
| Total Liabilities | 2.58B | 2.80B | 2.85B | 2.65B | 2.60B | 1.83B | 1.46B | 1.37B | 1.39B | 1.38B | 1.29B |
| Shareholders' Equity | 2.76B | 3.07B | 3.09B | 1.50B | 747M | 896M | 892M | 849M | 765M | 866M | 850M |
| Cash & Short-term Investments | 67.0M | 70.5M | 58.7M | 182M | 1.23B | 487M | 103M | 178M | 349M | 500M | 426M |
| Total Debt | 1.71B | 1.85B | 1.97B | 1.79B | 1.80B | 1.07B | 717M | 702M | 662M | 660M | 612M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 444M | 511M | 290M | 347M | 205M | 76.7M | 167M | 137M | 207M | 271M | 151M |
| Capital Expenditure | 39.3M | 49.3M | 48.9M | 31.9M | 28.8M | 32.2M | 29.7M | 33.3M | 22.0M | 18.5M | 16.0M |
| Free Cash Flow | 405M | 462M | 241M | 315M | 176M | 44.5M | 137M | 104M | 185M | 253M | 135M |
| Ratios | |||||||||||
| ROE | 11.8% | 10.4% | 8.7% | -99.9% | -106.6% | 14.6% | 7.4% | -7.1% | -13.0% | 19.1% | 18.3% |
| ROA | 6.1% | 5.5% | 4.5% | -36.1% | -23.8% | 4.8% | 2.8% | -2.7% | -4.6% | 7.4% | 7.3% |
| Net Profit Margin | 10.2% | 9.3% | 7.4% | -84.2% | -45.9% | 6.9% | 3.4% | -3.0% | -4.9% | 8.6% | 7.9% |
| Debt to Equity | 0.62x | 0.60x | 0.64x | 1.20x | 2.41x | 1.19x | 0.80x | 0.83x | 0.87x | 0.76x | 0.72x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pediatrix Medical Group, Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 470M | 5.72 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 526M | 6.15 | - |
| 2019 | USD 1.75B | 21 | - |
| 2018 | USD 2.22B | 24 | 827.7% |
| 2017 | USD 2.85B | 30 | 888.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Dec 20, 2013.
Who owns Pediatrix Medical Group, Inc.
- Insiders 3.13%
- Institutions 96.87%
- Public & others 0.00%
- Shares outstanding 78.1M
- Free float 74.9M
Top funds holding MD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4.78M | 6.12% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.63M | 3.37% | +0.39% | Sep 2026 |
| iShares Russell 2000 ETF | 2.09M | 2.68% | 0.00% | Oct 2026 |
| Victory Sycamore Small Company Opp R | 1.90M | 2.43% | -16.30% | Sep 2026 |
| Vanguard Small Cap Index | 1.83M | 2.34% | -3.01% | Sep 2026 |
| FullerThaler Behavioral Sm-Cp Eq R6 | 1.65M | 2.11% | +39.86% | Jun 2026 |
| Vanguard MStar Small Cap Value Index | 1.19M | 1.52% | -0.86% | Sep 2026 |
| DFA U.S. Small Cap Value I | 1.04M | 1.34% | +34.70% | Sep 2026 |
| Fidelity Small Cap Index | 912K | 1.17% | +0.15% | Aug 2026 |
| Wasatch Small Cap Value | 849K | 1.09% | -14.30% | Sep 2026 |
| iShares Russell 2000 Value ETF | 774K | 0.99% | 0.00% | Oct 2026 |
| Vanguard Strategic Equity Inv | 750K | 0.96% | 0.00% | Sep 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 727K | 0.93% | -0.05% | Oct 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 714K | 0.91% | -0.36% | Oct 2026 |
| Fidelity Select Health Care Svcs Port | 644K | 0.82% | -3.95% | Sep 2026 |
| Invesco S&P SmallCap Momentum ETF | 624K | 0.80% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 603K | 0.77% | +5.29% | Sep 2026 |
| Oberweis Micro-Cap | 602K | 0.77% | -10.54% | Jun 2026 |
| American Century Small Cap Value Inv | 601K | 0.77% | -45.90% | Sep 2026 |
| Vanguard Tax-Managed Small Cap Adm | 542K | 0.69% | 0.00% | Sep 2026 |
Top institutions holding MD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 13.7M | 17.55% | +1.03% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 5.99M | 7.66% | -2.75% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 4.41M | 5.64% | +4.40% | Sep 2026 |
| Vanguard Capital Management, LLC | 3.62M | 4.63% | -0.99% | Jun 2026 |
| State Street Corp | 3.53M | 4.52% | +4.58% | Jun 2026 |
| Victory Capital Management Inc. | 3.42M | 4.37% | -11.06% | Jun 2026 |
| Wasatch Advisors LP | 2.50M | 3.20% | +21.87% | Jun 2026 |
| Geode Capital Management, LLC | 2.23M | 2.85% | +1.74% | Jun 2026 |
| LSV Asset Management | 1.73M | 2.21% | +45.03% | Sep 2026 |
| Fuller & Thaler Asset Management Inc | 1.72M | 2.20% | +40.02% | Jun 2026 |
| Allspring Global Investments Holdings, LLC | 1.62M | 2.07% | +66.02% | Jun 2026 |
| D. E. Shaw & Co LP | 1.61M | 2.06% | -5.58% | Jun 2026 |
| American Century Companies Inc | 1.35M | 1.72% | -38.53% | Sep 2026 |
| Rockefeller Capital Management L.P. | 1.34M | 1.71% | +75.55% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.33M | 1.70% | +6.23% | Jun 2026 |
| Charles Schwab Investment Management Inc | 1.29M | 1.66% | -10.34% | Jun 2026 |
| Amvescap Plc. | 1.17M | 1.50% | +27.27% | Jun 2026 |
| Public Sector Pension Investment Board | 988K | 1.26% | +134.42% | Jun 2026 |
| Northern Trust Corp | 934K | 1.20% | +3.78% | Jun 2026 |
| Royce & Associates, LP | 914K | 1.17% | +34.71% | Jun 2026 |
Pediatrix Medical Group, Inc. company profile
- Company name
- Pediatrix Medical Group, Inc.
- Ticker
- MD.US
- Exchange
- USA Stocks
- Listed since
- Sep 19, 1995
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 4,280
- Fiscal year end
- December
- Address
- 1301 Concord Terrace, Sunrise, FL, United States, 33323
- Phone
- 954 384 0175
- Website
- pediatrix.com
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Pediatrix Medical Group, Inc. management
10- Mr. Mark S. OrdanCEO & Executive Chairman · born 1959
- Ms. Kasandra H. RossiExecutive VP, Treasurer & CFO · born 1973
- Mr. D. Gregory NeebExecutive VP & Chief Operating and Strategy Officer · born 1968
- Mr. John C. PepiaSenior VP & Chief Accounting Officer · born 1963
- Ms. Cheryl M. VanPattenSenior VP & Chief Information Officer
- Mr. David HaddockExecutive Vice President, General Counsel & Secretary
- Ms. Debra McRobertsSenior Vice President of People Services
- Mr. Kevin PitzerPresident of West Division
- Mr. Mike AshfordPresident of South Central Division
- Dr. Michael Dwyer M.D.Chief Medical Officer of South Central Division